WebSubject: Nanna Acquisition Gives Astellas Mitochondrial Expertise Add a personalized message to your email. Cancel. Send. Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe. WebApr 24, 2024 · This is Astellas’ second acquisition of the year. Tokyo-based multinational pharma company Astellas announced earlier this week that it had acquired U.K.-based biotech company Nanna Therapeutics, through a share purchase agreement executed by its UK subsidiary, Astellas Pharma Europe Ltd.
Primary Focus: Mitochondria Astellas Pharma Inc.
WebApr 22, 2024 · Tokyo, Cambridge: Astellas Pharma Inc. and Nanna Therapeutics Limited have announced that Astellas has acquired Nanna, a biotech company headquartered in the United Kingdom, that is focused on addressing age-related diseases with high unmet medical need including mitochondria-related diseases. WebAstellas has established a team with strong expertise at Mitobridge, in Cambridge, Massachusetts, and at Nanna Therapeutics, in Cambridge, United Kingdom, discovering novel therapeutics that improve mitochondrial functions and advancing them into the clinic. cari ijazah
Astellas and Nanna Therapeutics ink $15M tie-up - BioWorld
WebJul 30, 2024 · Astellas Pharma Inc. is a pharmaceutical company conducting business in more than 70 countries around the world. We are promoting the Focus Area Approach … WebApr 21, 2024 · Astellas, through its subsidiary in the United Kingdom, Astellas Pharma Europe Ltd., has purchased all of the issued share capital of Nanna through execution of … WebApr 24, 2024 · Astellas Pharma paid roughly $15 million to acquire UK-based Nanna Therapeutics, which is developing therapies that modulate function of the cell’s power … cariitti projektori